Weight loss treatment can be life changing when you are informed, supported and guided by experienced professionals
Wegovy (semaglutide) was approved by the Food and Drug Administration (FDA) as a weight loss medication in 2021
Edens digital platform streamlines access to independent healthcare professionals who can assess patients and determine eligibility for treatments like GLP-1 receptor agonists, including compounded semaglutide
however, there are limited human studies
expectations regarding our mobile applications, market acceptance, user experience, customer retention, brand development, our ability to invest and generate a return on any such investment, customer acquisition costs, operating efficiencies and leverage (including our fulfillment capabilities), the effect of any pricing decisions, changes in our product or offering mix, the timing and market acceptance of any new products or offerings, the success of our business model, our market opportunity, our ability to scale our business, the growth of certain of our specialties, our ability to innovate on and expand the scope of our offerings and experiences, our ability to reinvest into the customer experience, and our ability to comply with the extensive, complex and evolving regulatory requirements applicable to our business, including without limitation state and federal healthcare, privacy and consumer protection laws and regulations